Tripartite Motif-Containing Protein 28 Is a Small Ubiquitin-Related Modifier E3 Ligase and Negative Regulator of IFN Regulatory Factor 7
- 1 November 2011
- journal article
- Published by The American Association of Immunologists in The Journal of Immunology
- Vol. 187 (9), 4754-4763
- https://doi.org/10.4049/jimmunol.1101704
Abstract
IFN regulatory factor 7 (IRF7) is a potent transcription factor of type I IFNs and IFN-stimulated genes and is known as the master regulator of type I IFN-dependent immune responses. Because excessive responses could harm the host, IRF7 itself is delicately regulated at the transcriptional, translational, and posttranslational levels. Modification of IRF7 by small ubiquitin-related modifiers (SUMOs) has been shown to regulate IFN expression and antiviral responses negatively, but the specific E3 ligase needed for IRF7 SUMOylation has remained unknown. As reported in this article, we have identified the tripartite motif-containing protein 28 (TRIM28) as a binding partner of IRF7. We have demonstrated that TRIM28 also interacts with the SUMO E2 enzyme and increases SUMOylation of IRF7 both in vivo and in vitro, suggesting it acts as a SUMO E3 ligase of IRF7. Unlike the common SUMO E3 ligase, protein inhibitor of activated STAT1, the E3 activity of TRIM28 is specific to IRF7, because it has little effect on IRF7’s close relative IRF3. TRIM28 is therefore, so far as we know, the first IRF7-specific SUMO E3 reported. TRIM28-mediated SUMOylation of IRF7 is increased during viral infection, and SUMOylation of transcription factors usually results in transcriptional repression. Overexpression of TRIM28 therefore inhibits IRF7 transactivation activity, whereas knockdown of TRIM28 has the opposite effect and potentiates IFN production and antiviral responses. Collectively, our results suggest that TRIM28 is a specific SUMO E3 ligase and negative regulator of IRF7.Keywords
This publication has 63 references indexed in Scilit:
- SUMO E3 ligase activity of TRIM proteinsOncogene, 2010
- The A20 Deubiquitinase Activity Negatively Regulates LMP1 Activation of IRF7Journal of Virology, 2010
- A genome-wide RNAi screen identifies a new transcriptional module required for self-renewalGenes & Development, 2009
- Epstein-Barr Virus LF2: an Antagonist to Type I InterferonJournal of Virology, 2009
- TRIM family proteins and their emerging roles in innate immunityNature Reviews Immunology, 2008
- Small Ubiquitin-related Modifier (SUMO) Binding Determines Substrate Recognition and Paralog-selective SUMO ModificationJournal of Biological Chemistry, 2008
- Virus Infection Triggers SUMOylation of IRF3 and IRF7, Leading to the Negative Regulation of Type I Interferon Gene ExpressionPublished by Elsevier BV ,2008
- Inhibition of Interferon Regulatory Factor 7 (IRF7)-Mediated Interferon Signal Transduction by the Kaposi's Sarcoma-Associated Herpesvirus Viral IRF Homolog vIRF3Journal of Virology, 2007
- TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activityNature, 2007
- SUMOsp: a web server for sumoylation site predictionNucleic Acids Research, 2006